Skip to content
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM BIO INNOVATION
JLM COMPANIES
JLM LANDSCAPE
BIOTIPS
BLOG
BRIEFS
JOIN US
Our Partners
Become a Partner
JLM-BIOSYNERGY
CONTACT US
Search for:
Menu
Close
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM BIO INNOVATION
JLM COMPANIES
JLM LANDSCAPE
BIOTIPS
BLOG
BRIEFS
JOIN US
Our Partners
Become a Partner
JLM-BIOSYNERGY
CONTACT US
20211103 AlphaTAU banner banner
Home
>
Alpha TAU Enrolls Its First Patient in Combination Trial of Alpha DaRT™ & Pembrolizumab (Keytruda)
>
20211103 AlphaTAU banner banner